Skip to content
XYL

Xylem Inc.

Xylem Inc. Q1 FY2025 earnings call

April 29, 2025 · fiscal period ended 2025-03

EPS · actual vs est

$1.03 / $0.95Beat +7.9%

Revenue · actual vs est

$2.07B / $2.04BBeat +1.4%
Ask about this call

Summary

Generated 2025-04-29

Management highlights

Management Statement and Operational Highlights

  • Team had strong Q1, exceeding expectations with revenue growth across segments, 20 basis points EBITDA margin expansion, and double-digit EPS growth. Book to bill remained above 1.
  • Leaning into high-impact culture, simplifying processes/systems, and reorienting structure for improved customer focus. Reaffirmed full-year 2025 guidance based on current tariff levels.
  • Achieved cost synergies faster than planned in Evoqua integration, with strong momentum on revenue synergies. Active M&A pipeline, including acquisition of Baycom (a leading technology company in zero liquid discharge).
  • Exceeded 2025 sustainability goals, with annual sustainability report out April 30, and raised 2030 sustainability goals.
View in transcript ↓

Segment performance

Segment Performance

  • Measurement and Control Solutions (MCS): Total backlog at $1.8 billion, orders down 8% (driven by tough comps in smart metering, partially offset by analytics growth), revenue up 6% vs prior year (driven by energy growth, offset by water delivery calibration), EBITDA margin 21% (down 170 basis points y/y due to energy-water mix challenges).
  • Water Infrastructure: Orders up 1%, revenue up 5%, EBITDA margin up 290 basis points (driven by productivity and price offsetting inflation and mix).
  • Applied Water: Orders up 3% (fifth straight quarter growth), revenue up 1% (driven by building solutions, offset by 80/20 walkaway impacts), segment EBITDA margin up 300 basis points y/y.
  • Water Solutions and Services: Orders down 5% (lapping tough comp), revenue up 1% (strength in services offset by weather impacts in SE US), segment EBITDA margin down 60 basis points y/y (driven by mix and lower volume).
View in transcript ↓

Guidance

Guidance

  • Full year reported revenue expected $8.7 billion to $8.8 billion (up from prior $8.6 billion to $8.7 billion), organic revenue growth 3% to 4% (unchanged), EBITDA margin 21.3% to 21.8% (70-120 basis points expansion), EPS $4.50 to $4.70.
  • Q2 revenue growth 1% to 2% reported, 2% to 3% organic; EBITDA margin ~21% to 21.5% (flat to up 50 basis points); EPS $1.12 to $1.16.
  • MCS EBITDA margin expected to be low in Q2, then improve sequentially and expand in the second half.
View in transcript ↓

Risks

Risks

  • Tariff uncertainties, including potential changes in tariff rates and their impact on demand.
  • Inflation, currency fluctuations, and interest rate changes that could affect business performance.
View in transcript ↓

Q&A highlights

Question and Answer

  • Q: Did customers preposition inventory ahead of tariffs?

A: No significant pull-ins seen; only small impact in Applied Water commercial business.

  • Q: How is Xylem managing pricing related to tariffs?

A: Mix of surcharges and price increases, active and nimble in adjusting to evolving tariff situations.

  • Q: Details on M&A and capital deployment?

A: Active M&A pipeline focused on core capabilities, including acquisitions, with plans for dividends and share buybacks.

  • Q: Is the Water Solutions and Services segment lumpy?

A: Yes, it's the lumpiest segment, but fundamentals strong with backlog up 6% to 7% year over year.

  • Q: How does tariff impact Xylem's competitive position?

A: Diversified portfolio helps maintain a strong competitive position despite tariff challenges.

  • Q: What's the impact of organizational realignment?

A: Teams are more focused, decisions are quicker, with 16 division GMs having end-to-end P&L accountability for improved customer focus.

  • Q: Outlook for MCS margin?

A: MCS EBITDA margin expected to be low in Q2, then improve sequentially and expand in the second half.

  • Q: Impact of 80/20 on orders?

A: Built into guidance with a ~1% headwind, no material change with tariffs as incremental pricing provides tailwind if no major demand pullback.

  • Q: Trends in April orders?

A: Tracking to forecasting, no major pullbacks yet, with some project delays on industrial treatment side within normal hedging scope.

  • Q: Sequential margin dynamics in MCS?

A: Q2 expected to be low, then sequential improvement starting in Q3 and continuing into Q4.

  • Q: Book to bill outlook for second half?

A: Normal order pattern expected as projects rephase, leading to above-one book to bill in the second half.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$1.03$0.95+7.9%$0.90
Revenue$2.07B$2.04B+1.4%$2.03B

Transcript

April 29, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.